Skip to content

Evaluation of Pacemaker Algorithms to Avoid Unnecessary Right Ventricular Pacing

AV-Hysteresis Versus Mode Switch to AAI (MVP) for the Avoidance of Unnecessary Right Ventricular Pacing

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01803217
Acronym
ADVANTAGE
Enrollment
70
Registered
2013-03-04
Start date
2007-11-30
Completion date
2016-06-30
Last updated
2017-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pacemaker Implantation for Sinus Node Disease

Brief summary

Unnecessary right ventricular pacing has been shown to be detrimental in recipients of implantable pacemaker or defibrillators. The ADVANTAGE study evaluates the efficacy of two pacemaker based algorithms (atrioventricular hysteresis function versus mode switch to atrial pacing) to reduce right ventricular pacing.

Detailed description

Comparison of the effect of an atrioventricular hysteresis function with a mode switch to atrial pacing on the right ventricular pacing percentage in a multi-centre, prospective, randomized, single blinded, cross-over study.

Interventions

OTHERpacemaker programming to mode switch to atrial pacing versus atrioventricular hysteresis function

Sponsors

Klinikum Bamberg
CollaboratorOTHER
Krankenhaus Peißenberg
CollaboratorUNKNOWN
Medtronic
CollaboratorINDUSTRY
Deutsches Herzzentrum Muenchen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Indication for the implantation of a dual-chamber pacemaker

Exclusion criteria

Persistent or permanent atrial tachyarrhythmias atrioventricular block 2nd or 3rd degree indication or the implantation of an defibrillator

Design outcomes

Primary

MeasureTime frame
Right ventricular pacing percentage3 months

Secondary

MeasureTime frame
BNP levels3 months

Other

MeasureTime frame
Occurrence of atrial tachyarrhythmias3 months

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026